
The episode discusses the potential effectiveness of luvesilocin, a psychedelic substance, in treating postpartum depression.
Nearly one in five new moms experiences anxiety or depression during pregnancy or after giving birth. These conditions can lead to difficulty bonding with a newborn, or a higher risk of suicide, if left untreated. But a new experimental treatment is giving some researchers hope. It's a psychoactive substance derived from mushrooms called luvesilocin. In a recent set of FDA trials , a single dose of luvesilocin turned out to be highly effective – and worked more quickly – in improving patients' postpartum depression and anxiety. Dr. Camille Hoffman is an OB-GYN and Professor of Maternal Fetal Medicine at the University of Colorado Anschutz. She helped oversee an early clinical study of luvesilocin, and wrote about it for The Conversation . Hoffman spoke with Erin O'Toole about what researchers found, and why luvesilocin may be a promising alternative to psychotherapy or prescription drugs that are often used to treat postpartum depression. * * * * * Sign up for the In The NoCo newsletter: Visit KUNC.org Questions? Feedback? Story ideas? Email us: NOCO@KUNC.org Like what you're hearing? Help more people discover In The NoCo by rating the show on your favorite podcast app. Thanks…
Host: Erin O'Toole
Guest: Dr. Camille Hoffman
Organizations: University of Colorado Anschutz, KUNC
Products: luvesilocin
Explore listener stats, chart rankings, contacts and more on the In The NOCO podcast page.